| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |